• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[无可用内容]

[Not Available].

作者信息

Kefi Asma, Helali Wiem, Ben Abdelghani Khaoula, El Euch Mounira, Sassi Cyrine, Turki Sami, Abderrahim Ezzeddine

机构信息

Department of Internal Medicine A, Charles Nicolle hospital, Tunis, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.

出版信息

Tunis Med. 2023 Oct 5;101(10):765-769.

PMID:38465758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11261505/
Abstract

INTRODUCTION

Sarcoidosis is a systemic granulomatosis that can be associated with large-scale physical and mental disability, affecting the health related quality-of-life (HRQoL) of patients.

AIM

To evaluate the HRQoL of tunisian patients with sarcoidosis and to identify the factors that influence it.

METHODS

We conducted an analytical, cross-sectional study collecting 31 patients with sarcoidosis according to the ATS/ERS/WASOG criteria. The evaluation of the HRQoL was assessed by two questionnaires in tunisian dialect. The generic score was the Medical Outcome Study 36-Short Form Health Survey (SF-36).The specific score used was the Sarcoidosis Health Questionnaire (SHQ).

RESULTS

The HRQoL of our 31 patients was more affected in the three domains of the SHQ compared to the SF-36, which is in favor of the better sensitivity of the SHQ to detect the influence of the extent of sarcoidosis on the HRQoL. Factors associated with more impaired HRQoLwere: age at disease onset, age at interview, comorbidities, altered spirometry results, ocular involvement, chronic cholestasis, splenic nodules, arthralgia, organ count ≥3, lymphopenia and cholestasis at the time of the interview. Taking an immunosuppressant agent, particularly Methotrexate, was associated with HRQoL improvement. The number of relapses was the most correlated factor with an altered HRQoL, and this in several domains.

CONCLUSION

For an effective management of patients with sarcoidosis, a bio-psycho-social approach is now necessary in order to assess the real and global impact of the disease and to improve the HRQoL of patients. Disease-specific scores seem more reliable in achieving these goals.

摘要

引言

结节病是一种全身性肉芽肿病,可导致严重的身心残疾,影响患者的健康相关生活质量(HRQoL)。

目的

评估突尼斯结节病患者的HRQoL,并确定影响其的因素。

方法

我们进行了一项分析性横断面研究,根据美国胸科学会(ATS)/欧洲呼吸学会(ERS)/世界结节病和其他肉芽肿病协会(WASOG)标准收集了31例结节病患者。采用两份突尼斯方言问卷对HRQoL进行评估。通用评分采用医学结局研究36项简短健康调查(SF-36)。使用的特定评分是结节病健康问卷(SHQ)。

结果

与SF-36相比,我们的31例患者的HRQoL在SHQ的三个领域受影响更大,这表明SHQ在检测结节病程度对HRQoL的影响方面具有更高的敏感性。与HRQoL受损更严重相关的因素包括:发病年龄、访谈时年龄、合并症、肺功能测定结果异常、眼部受累、慢性胆汁淤积、脾结节、关节痛、受累器官数≥3、淋巴细胞减少和访谈时胆汁淤积。服用免疫抑制剂,尤其是甲氨蝶呤,与HRQoL改善相关。复发次数是与HRQoL改变最相关的因素,且在多个领域均如此。

结论

为了有效管理结节病患者,现在需要采用生物-心理-社会方法来评估疾病的实际和整体影响,并改善患者的HRQoL。疾病特异性评分在实现这些目标方面似乎更可靠。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2388/11261505/f394f08ad9bb/capture6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2388/11261505/d9ce3f0adff9/capture1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2388/11261505/b908779362bb/capture2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2388/11261505/c523463b6408/capture3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2388/11261505/e0e8073e9d47/capture4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2388/11261505/8e8b508fecf7/capture5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2388/11261505/f394f08ad9bb/capture6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2388/11261505/d9ce3f0adff9/capture1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2388/11261505/b908779362bb/capture2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2388/11261505/c523463b6408/capture3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2388/11261505/e0e8073e9d47/capture4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2388/11261505/8e8b508fecf7/capture5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2388/11261505/f394f08ad9bb/capture6.jpg

相似文献

1
[Not Available].[无可用内容]
Tunis Med. 2023 Oct 5;101(10):765-769.
2
Validation of the Japanese version of the Sarcoidosis Health Questionnaire: a cross-sectional study.《Sarcoidosis Health Questionnaire 日译本的验证:一项横断面研究》。
Health Qual Life Outcomes. 2011 May 14;9:34. doi: 10.1186/1477-7525-9-34.
3
Can the Sarcoidosis Health Questionnaire predict the long-term outcomes in Japanese sarcoidosis patients?《Sarcoidosis Health Questionnaire 能否预测日本结节病患者的长期结局?》
Respir Med. 2019 Mar;149:1-8. doi: 10.1016/j.rmed.2019.01.001. Epub 2019 Jan 11.
4
Health related quality of life regarding to gender in sarcoidosis.结节病中与性别相关的健康相关生活质量。
Coll Antropol. 2009 Sep;33(3):837-40.
5
Distance saturation product predicts health-related quality of life among sarcoidosis patients.距离饱和度产物可预测结节病患者的健康相关生活质量。
Health Qual Life Outcomes. 2012 Jun 13;10:67. doi: 10.1186/1477-7525-10-67.
6
Validation of the Sarcoidosis Health Questionnaire in a non-US population.验证 Sarcoidosis Health Questionnaire 在非美国人群中的适用性。
Respirology. 2012 Apr;17(3):519-24. doi: 10.1111/j.1440-1843.2012.02134.x.
7
Quality of life in sarcoidosis: comparing the impact of ocular and non-ocular involvement of the disease.结节病的生活质量:比较疾病眼部和非眼部受累的影响。
Ophthalmic Epidemiol. 2010 Aug;17(4):217-24. doi: 10.3109/09286586.2010.483754.
8
The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis.皮质类固醇对结节病门诊患者生活质量的影响:倾向分析结果
Respir Med. 2015 Apr;109(4):526-31. doi: 10.1016/j.rmed.2015.01.019. Epub 2015 Feb 7.
9
Administering the Sarcoidosis Health Questionnaire to sarcoidosis patients in Serbia.向塞尔维亚的结节病患者发放结节病健康调查问卷。
J Bras Pneumol. 2016 Apr;42(2):99-105. doi: 10.1590/S1806-37562015000000063.
10
Validation of the Turkish Version of the Sarcoidosis Health Questionnaire: A cross-sectional study.结节病健康问卷土耳其语版本的验证:一项横断面研究。
Sarcoidosis Vasc Diffuse Lung Dis. 2023 Mar 28;40(1):e2023002. doi: 10.36141/svdld.v40i1.13617.

本文引用的文献

1
ERS clinical practice guidelines on treatment of sarcoidosis.ERS 临床实践指南:结节病的治疗。
Eur Respir J. 2021 Dec 16;58(6). doi: 10.1183/13993003.04079-2020. Print 2021 Dec.
2
The indications for the treatment of sarcoidosis: Wells Law.结节病的治疗指征:韦尔斯法则。
Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(4):280-282. doi: 10.36141/svdld.v34i4.6957. Epub 2017 Apr 28.
3
Can the Sarcoidosis Health Questionnaire predict the long-term outcomes in Japanese sarcoidosis patients?《Sarcoidosis Health Questionnaire 能否预测日本结节病患者的长期结局?》
Respir Med. 2019 Mar;149:1-8. doi: 10.1016/j.rmed.2019.01.001. Epub 2019 Jan 11.
4
Toxicity risk from glucocorticoids in sarcoidosis patients.类肉瘤病患者糖皮质激素的毒性风险。
Respir Med. 2017 Nov;132:9-14. doi: 10.1016/j.rmed.2017.09.003. Epub 2017 Sep 8.
5
Fatigue and health-related quality of life in patients with pulmonary sarcoidosis treated by oral Corticosteroids.口服皮质类固醇治疗的肺结节病患者的疲劳及健康相关生活质量
Sarcoidosis Vasc Diffuse Lung Dis. 2016 Aug 1;33(2):124-9.
6
Administering the Sarcoidosis Health Questionnaire to sarcoidosis patients in Serbia.向塞尔维亚的结节病患者发放结节病健康调查问卷。
J Bras Pneumol. 2016 Apr;42(2):99-105. doi: 10.1590/S1806-37562015000000063.
7
The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis.皮质类固醇对结节病门诊患者生活质量的影响:倾向分析结果
Respir Med. 2015 Apr;109(4):526-31. doi: 10.1016/j.rmed.2015.01.019. Epub 2015 Feb 7.
8
Racial difference in sarcoidosis mortality in the United States.美国结节病死亡率的种族差异。
Chest. 2015 Feb;147(2):438-449. doi: 10.1378/chest.14-1120.
9
Current and emerging pharmacological treatments for sarcoidosis: a review.结节病的当前及新兴药物治疗:综述
Drug Des Devel Ther. 2013 Apr 12;7:325-38. doi: 10.2147/DDDT.S31064. Print 2013.
10
Translation in Arabic, adaptation and validation of the SF-36 Health Survey for use in Tunisia.SF-36 健康调查在突尼斯的阿拉伯语翻译、改编和验证。
Ann Phys Rehabil Med. 2012 Sep;55(6):388-403. doi: 10.1016/j.rehab.2012.05.003. Epub 2012 Jun 21.